Singapore biotech 'leading the way' in machine learning and combinatorial genetics secures $43m in funding
Engine Biosciences, a Singapore- and Silicon Valley-based company with an artificial intelligence-enabled technology platform that is designed to discover new biology targets and disease-causing links amongst known targets, has generated US$43m in a Series A funding round.
Source: biopharma-reporter.com